141 related articles for article (PubMed ID: 31774712)
1. Eliminating Deaths From Cervical Cancer-Report of a Panel at the 7th Annual Symposium on Global Cancer Research, a Satellite Meeting at the Consortium of Universities for Global Health 10th Annual Meeting.
Binagwaho A; Garcia PJ; Gueye B; Dykens JA; Simelela N; Torode J; Goba G; Bosland MC
J Glob Oncol; 2019 Nov; 5():1-7. PubMed ID: 31774712
[TBL] [Abstract][Full Text] [Related]
2. Towards the global elimination of cervical cancer.
Canfell K
Papillomavirus Res; 2019 Dec; 8():100170. PubMed ID: 31176807
[TBL] [Abstract][Full Text] [Related]
3. Eliminating Cervical Cancer in Mali and Senegal, Two Sub-Saharan Countries: Insights and Optimizing Solutions.
Haque A; Kouriba B; Aïssatou N; Pant A
Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32295116
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer: a call for political will.
Pollack AE; Balkin MS; Denny L
Int J Gynaecol Obstet; 2006 Sep; 94(3):333-42. PubMed ID: 16857201
[TBL] [Abstract][Full Text] [Related]
5. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
[TBL] [Abstract][Full Text] [Related]
6. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
[TBL] [Abstract][Full Text] [Related]
7. Global elimination of cervical cancer is achievable-with commitment.
The Lancet Oncology
Lancet Oncol; 2019 Nov; 20(11):1467. PubMed ID: 31674306
[No Abstract] [Full Text] [Related]
8. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC.
MMWR Recomm Rep; 1997 Jun; 46(RR-11):1-20. PubMed ID: 9213745
[TBL] [Abstract][Full Text] [Related]
9. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention].
Kohl I
Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):91-7. PubMed ID: 17051469
[TBL] [Abstract][Full Text] [Related]
10. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
[TBL] [Abstract][Full Text] [Related]
12. Recommendations for cervical cancer prevention in Latin America and the Caribbean.
Muñoz N; Franco EL; Herrero R; Andrus JK; de Quadros C; Goldie SJ; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 11():L96-L107. PubMed ID: 18945407
[TBL] [Abstract][Full Text] [Related]
13. Trends in cervical cancer mortality in the Americas.
Robles SC; White F; Peruga A
Bull Pan Am Health Organ; 1996 Dec; 30(4):290-301. PubMed ID: 9041740
[TBL] [Abstract][Full Text] [Related]
14. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
[TBL] [Abstract][Full Text] [Related]
15. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
16. Mathematical models of cervical cancer prevention in Latin America and the Caribbean.
Goldie SJ; Diaz M; Constenla D; Alvis N; Andrus JK; Kim SY
Vaccine; 2008 Aug; 26 Suppl 11():L59-72. PubMed ID: 18945403
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer control in Latin America: A call to action.
Bychkovsky BL; Ferreyra ME; Strasser-Weippl K; Herold CI; de Lima Lopes G; Dizon DS; Schmeler KM; Del Carmen M; Randall TC; Nogueira-Rodrigues A; de Carvalho Calabrich AF; St Louis J; Vail CM; Goss PE
Cancer; 2016 Feb; 122(4):502-14. PubMed ID: 26670695
[TBL] [Abstract][Full Text] [Related]
18. Workshop on screening for cancer of the uterine cervix in Central America.
Miller AB; Robles SC
Bull Pan Am Health Organ; 1996 Dec; 30(4):397-408. PubMed ID: 9041753
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer prevention in Senegal: an International Cooperation Project Report.
Gabrielli S; Maggioni E; Fieschi L
Acta Biomed; 2018 Jul; 89(6-S):29-34. PubMed ID: 30038201
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer in sub-Saharan Africa: an emerging and preventable disease associated with oncogenic human papillomavirus.
Mboumba Bouassa RS; Prazuck T; Lethu T; Meye JF; Bélec L
Med Sante Trop; 2017 Feb; 27(1):16-22. PubMed ID: 28406406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
